乌干达HIV合并风湿性心脏病患者的临床结局、超声心动图表现与照护质量指标
本研究利用乌干达国家风湿性心脏病登记库,描述2009至2018年间73例HIV合并风湿性心脏病患者的超声心动图表现、临床特征、用药处方率及结局,并与365例年龄性别匹配的单纯风湿性心脏病患者比较。结果显示HIV合并组既往卒中/短暂性脑缺血发作率更高(12% vs 5%,P = .02),多因素调整后关联持续(OR 3.08,P = .03),但其他合并症、超声心动图表现、预防性青霉素处方率、临床照护保留率及死亡率两组相似。作者认为风湿性心脏病对该人群临床结局的影响可能大于HIV。
要点
- HIV合并风湿性心脏病患者以年轻女性为主,中位年龄36岁,86%为女性。
- 合并组既往卒中/短暂性脑缺血发作率高于单纯风湿性心脏病组(12% vs 5%,P = .02)。
- 两组全因死亡率、照护保留率及预防性青霉素处方率相似。
核心结论
- HIV合并风湿性心脏病患者卒中/TIA风险更高,但全因死亡率和风湿性心脏病照护质量指标与单纯风湿性心脏病患者相似。
- 作者认为风湿性心脏病对该人群临床结局的定义作用可能大于HIV。
研究设计与样本
- 利用乌干达国家风湿性心脏病登记库的回顾性队列研究,纳入2009至2018年间73例HIV合并风湿性心脏病患者。
- 对照组为365例年龄和性别匹配的单纯风湿性心脏病患者。
主要发现
- HIV合并风湿性心脏病组中位年龄36岁(IQR 15),86%为女性。
- HIV合并组既往卒中/短暂性脑缺血发作率为12%,单纯风湿性心脏病组为5%(P = .02)。
- 多因素调整后,HIV合并与卒中/TIA的关联持续(OR 3.08,P = .03)。
- 两组其他合并症患病率、超声心动图表现、预防性青霉素处方率、临床照护保留率及死亡率相似。
临床怎么用
- 对HIV合并风湿性心脏病患者应关注卒中/TIA风险评估与预防。
- 风湿性心脏病照护质量指标(如照护保留率)在该共病人群中与单纯风湿性心脏病患者相当,可沿用相应管理框架。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rheumatic heart disease (RHD) affects 41 million people worldwide, mostly in low- and middle-income countries, where it is co-endemic with human immunodeficiency virus (HIV). HIV is also a chronic inflammatory disorder associated with cardiovascular complications, yet the epidemiology of patients affected by both diseases is poorly understood. METHODS: Utilizing the Uganda National RHD Registry, we described the echocardiographic findings, clinical characteristics, medication prescription rates, and outcomes of all 73 people carrying concurrent diagnoses of HIV and RHD between 2009 and 2018. These individuals were compared to an age- and sex-matched cohort of 365 subjects with RHD only. RESULTS: The median age of the HIV-RHD group was 36 years (interquartile range [IQR] 15), and 86% were women. The HIV-RHD cohort had higher rates of prior stroke/transient ischemic attack (12% vs 5%, P = .02) than the RHD-only group, with this association persisting following multivariable adjustment (odds ratio [OR] 3.08, P = .03). Prevalence of other comorbidities, echocardiographic findings, prophylactic penicillin prescription rates, retention in clinical care, and mortality were similar between the 2 groups. CONCLUSIONS: Patients living with RHD and HIV in Uganda are a relatively young, predominantly female group. Although RHD-HIV comorbid individuals have higher rates of stroke, their similar all-cause mortality and RHD care quality metrics (such as retention in care) compared to those with RHD alone suggest rheumatic heart disease defines their clinical outcome more than HIV does. We believe this study to be one of the first reports of the epidemiologic profile and longitudinal outcomes of patients who carry diagnoses of both conditions.
引用
- Chang AY, Rwebembera J, Bendavid E, et al. Clinical Outcomes, Echocardiographic Findings, and Care Quality Metrics for People Living With Human Immunodeficiency Virus (HIV) and Rheumatic Heart Disease in Uganda. Clin Infect Dis. 2022. PMID: 34382644. doi:10.1093/cid/ciab681
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。